Levothroid and Ipratropium bromide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levothroid (levothyroxine sodium) and Ipratropium bromide (ipratropium bromide). Common drug interactions include thrombocytopenia among females and pericardial effusion among males.

The phase IV clinical study analyzes what interactions people have when they take Levothroid and Ipratropium bromide. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,974 Levothroid users. Check the latest studies of Levothroid.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.



On Jul, 26, 2026

37 people who take Levothroid and Ipratropium bromide together, and have interactions are studied.

Levothroid and Ipratropium bromide drug interactions.

What are the common drug interactions of Levothroid and Ipratropium Bromide, by gender? *:

female:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Pneumonia
  3. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  4. Serratia infection (bacterial infection)
  5. Staphylococcal infection (an infection with staphylococcus bacteria)
  6. Diarrhoea
  7. Activities of daily living impaired
  8. Back pain
  9. Cough
  10. Hypertension (high blood pressure)

male:

  1. Pericardial effusion (fluid around the heart)
  2. Ventricular extrasystoles (premature cardiac contraction)
  3. Diarrhoea
  4. Electrocardiogram qt prolonged
  5. Dehydration (dryness resulting from the removal of water)
  6. Hypoxia (low oxygen in tissues)
  7. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  8. Accident
  9. Acute sinusitis
  10. Angina pectoris (chest pain due to ischemia of the heart muscle)

What are the common drug interactions of Levothroid and Ipratropium Bromide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Upper respiratory tract infection
  2. Weight increased
  3. Wheezing (a high-pitched whistling sound made while you breath)
  4. Activities of daily living impaired
  5. Hypertension (high blood pressure)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Back pain
  8. Blood sodium decreased
  9. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  10. Confusional state

30-39:

n/a

40-49:

  1. Acute respiratory failure
  2. Diarrhoea
  3. Headache (pain in head)
  4. Hypotension (abnormally low blood pressure)
  5. Hypoxia (low oxygen in tissues)
  6. Nausea (feeling of having an urge to vomit)

50-59:

  1. Drug ineffective

60+:

  1. Pneumonia
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Unresponsive to stimuli
  5. Vomiting
  6. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  7. Faecal incontinence (a lack of control over passing stool)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Non-small cell lung cancer metastatic (type of epithelial lung cancer spreads to other parts)
  10. Pericardial effusion (fluid around the heart)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 10 people, 27.03%
  2. Insomnia (sleeplessness): 5 people, 13.51%
  3. High Blood Pressure: 5 people, 13.51%
  4. Pain: 4 people, 10.81%
  5. Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 3 people, 8.11%
  6. Itching: 3 people, 8.11%
  7. Idiopathic Pulmonary Fibrosis (chronic lung disease): 3 people, 8.11%
  8. Neuropathy Peripheral (surface nerve damage): 2 people, 5.41%
  9. High Blood Cholesterol: 2 people, 5.41%
  10. Asthma: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Levothroid and Ipratropium bromide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levothroid and Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levothroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levothroid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ipratropium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium and ipratropium bromide (the active ingredients of Levothroid and Ipratropium bromide, respectively), and Levothroid and Ipratropium bromide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: